News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Mayne Pharma Ventures Pty Ltd
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2019 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Acquired 362,121 shares
@ $0 |
|
| 12/19/2018 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Acquired 184,798 shares
@ $0 |
|
| 12/19/2018 |
SC 13D/A
| Mayne Pharma Ventures Pty Ltd reports a 59.1% stake in HedgePath Pharmaceuticals, Inc. |
| 11/05/2018 |
SC 13D/A
| Mayne Pharma Ventures Pty Ltd reports a 59% stake in HedgePath Pharmaceuticals, Inc. |
| 07/06/2018 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Bought 2,318,841 convertible preferred
@ $0
Bought 1,739,131 options to buy
@ $0 |
|
| 07/06/2018 |
SC 13D/A
| Mayne Pharma Ventures Pty Ltd reports a 59.1% stake in HedgePath Pharmaceuticals, Inc. |
| 02/12/2018 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Bought 600,000 shares
@ $162660, valued at
$97596M
|
|
| 01/11/2018 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Bought 3,478,261 convertible preferred
@ $0
Bought 2,608,696 options to buy
@ $0 |
|
| 01/11/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/02/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/28/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 11/15/2016 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 4,750,569 shares
@ $0
Exercised (in-or-at-the-money) 333 shares
@ $0
Exercised (in-or-at-the-money) 4,860,000 shares
@ $0
Exercised (in-or-at-the-money) 4,750,569 options to buy
@ $0.0878, valued at
$417.1k
Exercised (in-or-at-the-money) 333 options to buy
@ $0.075, valued at
$25
Exercised (in-or-at-the-money) 4,860,000 options to buy
@ $0.12, valued at
$583.2k
|
|
| 11/15/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 11/07/2016 |
SC 13D/A
| Mayne Pharma Ventures Pty Ltd reports a 59.3% stake in HedgePath Pharmaceuticals, Inc. |
| 11/07/2016 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 5,500,000 shares
@ $0
Exercised (in-or-at-the-money) 33,333,000 shares
@ $0
Exercised (in-or-at-the-money) 5,500,000 options to buy
@ $0.0878, valued at
$482.9k
Exercised (in-or-at-the-money) 33,333,000 options to buy
@ $0.075, valued at
$2.5M
|
|
| 06/16/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 05/27/2016 |
4
| Mayne Pharma Group Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 27,885,000 shares
@ $0
Granted 28,364,236 options to buy
@ $0.012, valued at
$340.4k
|
|
|
|